Table 2 Antibiotic susceptibility pattern of ESBL E. coli
Antibiotics | Antibiotic susceptibility of ESBL E. coli (n = 215) | |
|---|---|---|
Sensitive % (No) | Resistant % (No) | |
Amikacin(AK) | 91.6% (197) | 8.4% (18) |
Gentamicin(G) | 83.7% (180) | 16.3% (35) |
Ciprofloxacin(CIP) | 58.2% (125) | 41.8% (90) |
Ceftriaxone(CTR) | 0.0 (0) | 100% (215) |
Cefotaxime(CTX) | 2.7% (1) | 97.3% (214) |
Ceftazidime(CAZ) | 0.0 (0) | 100% (215) |
Nitrofurantoin(NIT)* | 93.8% (182) | 6.2% (12) |
Norfloxacin(NX)* | 56.2% (109) | 43.8% (85) |
Nalidixic acid(NA)* | 4.6% (9) | 95.4% (185) |
Ofloxacin(OF)* | 46.9% (91) | 53.1% (103) |
Tigecycline(TGC) | 100% (215) | 0.0 (0) |
Imipenem(IPM) | 68.8% (148) | 31.2% (67) |
Meropenem(MRP) | 90.2% (194) | 9.8% (21) |
Polymyxin B(PB) | 100% (215) | 0.0 (0) |
Colistin(CL) | 100% (215) | 0.0 (0) |